Healthcare provider profile · identity verified

Janette Marcelo, M.D.

Internal Medicine · MANHASSET, NY · NPI 1144337122

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	450	139
Atorvastatin Calcium	Atorvastatin Calcium	418	129
Losartan Potassium	Losartan Potassium	377	100
Levothyroxine Sodium	Levothyroxine Sodium	351	93
Amlodipine Besylate	Amlodipine Besylate	350	92
Metoprolol Succinate	Metoprolol Succinate	281	75
Metformin Hcl	Metformin Hcl	226	64
Pantoprazole Sodium	Pantoprazole Sodium	204	58
Glipizide Er	Glipizide	161	47
Simvastatin	Simvastatin	159	45
Escitalopram Oxalate	Escitalopram Oxalate	136	44
Zolpidem Tartrate	Zolpidem Tartrate	132	22
Synthroid	Levothyroxine Sodium	130	31
Lisinopril	Lisinopril	114	32
Famotidine	Famotidine	113	42
Montelukast Sodium	Montelukast Sodium	111	31
Gabapentin	Gabapentin	103	25
Tamsulosin Hcl	Tamsulosin Hcl	103	31
Albuterol Sulfate Hfa	Albuterol Sulfate	101	33
Alprazolam	Alprazolam	101	33
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	100	74
Omeprazole	Omeprazole	81	26
Donepezil Hcl	Donepezil Hcl	76	27
Metoprolol Tartrate	Metoprolol Tartrate	76	20
Hydrochlorothiazide	Hydrochlorothiazide	75	22
Lorazepam	Lorazepam	75	25
Jardiance	Empagliflozin	73	19
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	73	45
Atenolol	Atenolol	66	22
Ezetimibe	Ezetimibe	64	16
Fluticasone Propionate	Fluticasone Propionate	64	32
Allopurinol	Allopurinol	62	16
Azithromycin	Azithromycin	60	46
Pravastatin Sodium	Pravastatin Sodium	56	17
Eliquis	Apixaban	54	18
Ozempic	Semaglutide	54	14
Azelastine Hcl	Azelastine Hcl	51	13
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	49	22
Meloxicam	Meloxicam	49	24
Clopidogrel	Clopidogrel Bisulfate	48	15
Prednisone	Prednisone	46	24
Furosemide	Furosemide	43	19
Clonazepam	Clonazepam	41	12
Cefuroxime	Cefuroxime Axetil	40	30
Amoxicillin	Amoxicillin	39	28
Nebivolol Hcl	Nebivolol Hcl	39	11
Alendronate Sodium	Alendronate Sodium	38	11
Clobetasol Propionate	Clobetasol Propionate	38	17
Methylprednisolone	Methylprednisolone	38	32
Tramadol Hcl	Tramadol Hcl	38	suppressed
Metformin Hcl Er	Metformin Hcl	36	12
Meclizine Hcl	Meclizine Hcl	35	17
Ramipril	Ramipril	35	suppressed
Sertraline Hcl	Sertraline Hcl	34	suppressed
Carvedilol	Carvedilol	33	11
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Ibuprofen	Ibuprofen	32	suppressed
Labetalol Hcl	Labetalol Hcl	32	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Paroxetine Hcl	Paroxetine Hcl	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	12
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Lovastatin	Lovastatin	31	suppressed
Trazodone Hcl	Trazodone Hcl	31	suppressed
Finasteride	Finasteride	29	suppressed
Ondansetron Odt	Ondansetron	29	suppressed
Irbesartan	Irbesartan	27	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	27	suppressed
Memantine Hcl	Memantine Hcl	27	suppressed
Telmisartan	Telmisartan	26	suppressed
Fluocinonide	Fluocinonide	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Eszopiclone	Eszopiclone	23	suppressed
Glipizide	Glipizide	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	23	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Diazepam	Diazepam	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Lidocaine	Lidocaine	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Rybelsus	Semaglutide	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Valsartan	Valsartan	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Mupirocin	Mupirocin	16	15
Bupropion Hcl	Bupropion Hcl	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Levofloxacin	Levofloxacin	14	12
Nystatin	Nystatin	14	12
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Amiodarone Hcl	Amiodarone Hcl	13	suppressed
Ciclopirox	Ciclopirox	13	suppressed
Colchicine	Colchicine	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Lipitor	Atorvastatin Calcium	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	12	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error